Records containing: Irritable Bowel Syndrome

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2008-10-16
  Effect of Mesalazine on Low Grade Mucosal Inflammation in Irritable Bowel Syndrome. A Pilot Double Blind Placebo Controlled Study.
• CLINICAL_TRIALS study record update · 2008-10-01
  Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome. a 4-Week, Multicentre, Double-Blind, Randomised, Placebo-Controlled Phase IV Trial
• CLINICAL_TRIALS study record update · 2008-09-26
  A Dose-Ranging Study of the Pharmacodynamic Effects of BMS-562086 on Gastrointestinal Transit in Women With Diarrhea-Predominant Irritable Bowel Syndrome
• CLINICAL_TRIALS study record update · 2008-08-20
  Effect of Bifidobacterium on Irritable Bowel Syndrome
• CLINICAL_TRIALS study record update · 2008-06-17
  A Randomized, Double-Blind, Placebo-Controlled, Multicenter 2-Week Pilot Study to Evaluate the Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) Given Orally in Female Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2008-06-17
  A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study To Investigate The Effect Of Pd-217,014 In Patients With Irritable Bowel Syndrome (IBS)
• CLINICAL_TRIALS study record update · 2008-05-14
  A 24-wk, Prospective, d/b, Placebo Controlled, Parallel Group, Multicenter, Randomized/Withdrawal Efficacy and Safety Study of Dexloxiglumide for the Relief of Symptoms in Patients With Constipation-Predominant Irritable Bowel Syndrome
• CLINICAL_TRIALS study record update · 2008-05-14
  A 24-wk, Prospective, d/b, Placebo Controlled, Parallel Group, Multicenter, Randomized/Withdrawal Efficacy and Safety Study of Dexloxiglumide for the Relief of Symptoms in Patients With Constipation-Predominant Irritable Bowel Syndrome
• CLINICAL_TRIALS study record update · 2008-04-08
  A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Effectiveness of DDP733 in Female Patients With Irritable Bowel Syndrome With Constipation
• CLINICAL_TRIALS study record update · 2008-03-18
  Rifaximin in the Treatment of Small Intestinal Bacterial Overgrowth and IBS: Double Blind Randomized Controlled Trial (Multicenter Trial)
• CLINICAL_TRIALS study record update · 2008-02-15
  A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (c-IBS)
• CLINICAL_TRIALS study record update · 2008-02-15
  A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (c-IBS)
• CLINICAL_TRIALS study record update · 2007-11-16
  Bacteria and Cytokines as Factors Modulating Visceral Afferent Processing in Irritable Bowel Syndrome: Manipulation of Intestinal Bacteria and Mucosal Cytokines by Probiotic Therapy and the Effect on Visceral Hypersensitivity
• CLINICAL_TRIALS study record update · 2007-10-15
  A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Multiple Doses and Dose Levels of DDP225 in Female Patients With Irritable Bowel Syndrome With Diarrhea
• CLINICAL_TRIALS study record update · 2007-10-15
  Role Of Saccharomyces Boulardii In Diarrhea Dominant Irritable Bowel Syndrome
• CLINICAL_TRIALS study record update · 2007-05-28
  A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Multiple Doses and Dose Levels of DDP733 in Patients With Irritable Bowel Syndrome With Constipation
• CLINICAL_TRIALS study record update · 2006-10-20
  A Phase 2 Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of the Pharmacodynamic Effects of Orally Administered 100ug and 1000ug QD MD-1100 Acetate on Gastrointestinal Transit in Patients With Constipation Predominant Irritable Bowel Syndrome (C-IBS)
• CLINICAL_TRIALS study record update · 2006-10-20
  A Phase 2 Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of the Pharmacodynamic Effects of Orally Administered 100ug and 1000ug QD MD-1100 Acetate on Gastrointestinal Transit in Patients With Constipation Predominant Irritable Bowel Syndrome (C-IBS)
• CLINICAL_TRIALS study record update · 2006-08-25
  The Effect of Probioticson Bloating in IBS
• CLINICAL_TRIALS study record update · 2006-08-18
  ClinicalTrials.gov study NCT00065403
• CLINICAL_TRIALS study record update · 2006-08-18
  Acupuncture for Irritable Bowel Syndrome (IBS) Trial
• CLINICAL_TRIALS study record update · 2006-08-03
  Implicit Learning, Comorbidity and Stress Vulnerability in Chronic Functional Pain Syndromes